In the last trading session, 1.03 million Regulus Therapeutics Inc (NASDAQ:RGLS) shares changed hands as the company’s beta touched 0.35. With the company’s per share price at $7.87 changed hands at $0.0 or 0.00% during last session, the market valuation stood at $544.87M. RGLS’s last price was a discount, traded about -4.19% off its 52-week high of $8.20. The share price had its 52-week low at $0.83, which suggests the last value was 89.45% up since then.
Analysts gave the Regulus Therapeutics Inc (RGLS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.67. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended RGLS as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Regulus Therapeutics Inc (NASDAQ:RGLS) trade information
However, in the 30-day time frame, Regulus Therapeutics Inc (NASDAQ:RGLS) is 282.04% up.
The consensus price target for the stock as assigned by Wall Street analysts is 7, meaning bulls need a downside of -12.43% from its current market value. According to analyst projections, RGLS’s forecast low is 7 with 7 as the target high. To hit the forecast high, the stock’s price needs a 11.05% surge from its current level, while the stock would need to tank 11.05% for it to hit the projected low.
Regulus Therapeutics Inc (RGLS) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 40.21%. The 2025 estimates are for Regulus Therapeutics Inc earnings to decrease by -10.57%, but the outlook for the next 5-year period is at 11.89% per year.
Regulus Therapeutics Inc (NASDAQ:RGLS)’s Major holders
RA CAPITAL MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 9.6952% or 6.25 million shares worth $11.16 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund and Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund. With 7.88 shares estimated at $62.02 million under it, the former controlled 11.38% of total outstanding shares. On the other hand, Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund held about 10.71% of the shares, roughly 7.42 shares worth around $58.37 million.
